About Us Chronic Pain Our Brands Investors Contact Chronic Pain Chronic Pain: The Silent Epidemic Chronic pain has been called the ‘silent epidemic’; it gets very little attention despite the fact that its economic cost is greater than the cost of cancer, HIV, and heart disease combined. Given the cost of chronic pain – estimated to be $43 billion annually – it should be no surprise that its impact is far-reaching – affecting 1 in 5 Canadian adults. NeuPath Health was formed to specifically address this large and growing issue and our mission is to provide patients with the care and tools required to live a complete and fulfilled life; to reclaim the daily life activities taken by injury or illness. The majority of NeuPath’s efforts are focused on ‘high impact chronic pain patients’ (HICP). Representing approximately 5% of Canadian adults, HICP patients have difficulty going to work, going to school, taking care of themselves, or taking care of their families as a result of chronic pain. Increasingly, NeuPath is starting to connect with patients earlier in their chronic pain journey, in order to prevent the progression to HICP. Complex & Multifactorial Chronic pain is a complex condition driven by a number of biological, behavioural / psychological, and social factors. As a result, treatment plans developed by NeuPath’s licensed healthcare providers are multimodal and designed to address as many of these factors as possible. In addition to treating the pain sensation itself, NeuPath aims to educate patients and provide them with the confidence and tools required to better manage their chronic pain. Careers | Contact Terms of Use

About Us Chronic Pain Our Brands Investors Contact Careers NeuPath is always looking for talented, energetic, dedicated people who want to work in a fast-growing and fast-paced health care setting. If you are pursuing a career in medicine, nursing or medical administration, we would love to hear from you! Please submit your resume below. Name* . . Email* . . File Upload* Max. file size: 1 MB. Careers | Contact Terms of Use

About Us Chronic Pain Our Brands Investors Contact NeuPath Press Release NeuPath Health Revenue Growth Remains Strong at 26% in Q3 2021 NeuPathNovember 12, 2021News Total medical services revenue increased by 26% to $15.2 million in the quarter Same-clinic revenue growth of 14% YTD through September 30, 2021 11th consecutive quarter of positive adjusted EBITDA Expanded technology offering by closing acquisition of KumoCare and forming partnership with Cynergi Health Partners TORONTO, ONTARIO, November 12, 2021 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2021. All figures are in Canadian dollars, unless otherwise noted. Continue in PDF… Careers | Contact Terms of Use